Recommended Topic Related To:

Septocaine

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Septocaine

PATIENT INFORMATION

Loss of Sensation and Muscle Function:

Inform patients in advance of the possibility of temporary loss of sensation and muscle function following infiltration and nerve block injections [see ADVERSE REACTIONS].

Instruct patients not to eat or drink until normal sensation returns.

Last reviewed on RxList: 3/12/2010
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD